In a country where almost everything can be delivered within minutes, waiting 24-48 hours for essential medicines is a challenge that many Indians continue to face. Repill, a health-tech startup based ...

To apply a precision medicine approach to this disease, Character Bio has partnered with over 150 ophthalmology treatment ...

AISAP, an Israeli medical start-up, was named a top 2025 innovator by Fast Company, ranking 4th in healthcare for its AI tech ...

PARP7 is a mono-ADP-ribosyl transferase (mono-ART) which has recently gained attention due to its emerging role as a negative ...

The NIH announced the beginning of a phase 1 first-in-human trial of a vaccine for Lassa fever, a potentially fatal viral hemorrhagic disease for which there is no approved vaccine or treatment.

By incorporating healthspan science into clinical practice, some doctors are navigating a gray area between mainstream ...

Medical technology company Sibel Health has secured $30m in an equity financing round to expedite the commercial deployment ...

Hims & Hers Health is a top growth stock with strong cash flow, no debt, and an innovative AI-powered platform. Learn more on ...

Although cystic fibrosis is a single gene mutation, there are more than 1,000 different ways the CFTR gene can mutate in ...

Sibel Health's journey from Northwestern spinout to FDA-cleared medtech innovator showcases Chicago's rising potential in ...

Hims & Hers is shifting towards personalized medicine with AI-backed solutions. Find out why HIMS stock is buyable despite ...

Kiffik Biomedical, a leader in interstitial fluid (ISF)-based diagnostics, has announced a strategic partnership with Rubix LS, a pioneer in aptamer-based precision medicine, to develop a first-of-its ...